BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
Yosi Gilad, Michael Firer, Gary Gellerman. Recent Innovations in Peptide Based Targeted Drug Delivery to Cancer CellsBiomedicines 2016; 4(2): 11 doi: 10.3390/biomedicines4020011
William A. Hammond, Abhisek Swaika, Kabir Mody. Pharmacologic resistance in colorectal cancer: a reviewTherapeutic Advances in Medical Oncology 2016; 8(1): 57 doi: 10.1177/1758834015614530
Luigia Panariello, Marianna Donnarumma, Rosario Vincenzo Iaffaioli, Paolo Chiodini, Maria Carmela Annunziata, Tiziana Peduto, Gabriella Fabbrocini. Skin Toxicities During Colorectal Cancer Chemotherapy: Incidence and Pearls of Treatment in Our ExperienceClinical Colorectal Cancer 2020;  doi: 10.1016/j.clcc.2020.05.006
Andrew V Schally, Roberto Perez, Norman L Block, Ferenc G Rick. Potentiating effects of GHRH analogs on the response to chemotherapyCell Cycle 2015; 14(5): 699 doi: 10.1080/15384101.2015.1010893
MOON HEE LEE, SU-HYUN HONG, CHEOL PARK, GI-YOUNG KIM, SUN-HEE LEEM, SUNG HYUN CHOI, YOUNG-SAM KEUM, JIN WON HYUN, TAEG KYU KWON, SANG HOON HONG, YUNG HYUN CHOI. Hwang-Heuk-San induces apoptosis in HCT116 human colorectal cancer cells through the ROS-mediated activation of caspases and the inactivation of the PI3K/Akt signaling pathwayOncology Reports 2016; 36(1): 205 doi: 10.3892/or.2016.4812
Nicole Golob-Schwarzl, Caroline Schweiger, Carina Koller, Stefanie Krassnig, Margit Gogg-Kamerer, Nadine Gantenbein, Anna M. Toeglhofer, Christina Wodlej, Helmut Bergler, Brigitte Pertschy, Stefan Uranitsch, Magdalena Holter, Amin El-Heliebi, Julia Fuchs, Andreas Punschart, Philipp Stiegler, Marlen Keil, Jens Hoffmann, David Henderson, Hans Lehrach, Christoph Reinhard, Christian Regenbrecht, Rudolf Schicho, Peter Fickert, Sigurd Lax, Johannes Haybaeck. Separation of low and high grade colon and rectum carcinoma by eukaryotic translation initiation factors 1, 5 and 6Oncotarget 2017; 8(60): 101224 doi: 10.18632/oncotarget.20642
Ofer Levi, Assaf Shapira, Baruch Tal, Itai Benhar, Noam Eliaz. Isolating EGFR Overexpressing Carcinoma Cells from Human Whole Blood by Bio-FerrographyCytometry Part B: Clinical Cytometry 2014; : n/a doi: 10.1002/cytob.21212
Vitor A. Ungaro, Cleber W. Liria, Carolina D. Romagna, Natália J. S. Costa, Karine Philippot, Liane M. Rossi, M. Teresa Machini. A green route for the synthesis of a bitter-taste dipeptide combining biocatalysis, heterogeneous metal catalysis and magnetic nanoparticlesRSC Advances 2015; 5(46): 36449 doi: 10.1039/C5RA02641E
Apoptotic Effects of Drug Targeting Conjugates Containing Different GnRH Analogs on Colon Carcinoma CellsInternational Journal of Molecular Sciences 2019; 20(18): 4421 doi: 10.3390/ijms20184421
Shuai Wang, ChunHui Yin, XinYan Zhang, ZhiMei Shang, LiMin Huang, Nan Luo, AnQuan Wang, LingLing Dong, HongXing Liu, JingYan Zhu. Conversion to resectability using transcatheter arterial chemoembolization alternating with mFOLFOX6 in patients with colorectal liver metastasesJournal of Research in Medical Sciences 2019; 24(1): 92 doi: 10.4103/jrms.JRMS_879_16
Klara Fodor, Nikoletta Dobos, Andrew Schally, Zita Steiber, Gabor Olah, Eva Sipos, Lorant Szekvolgyi, Gabor Halmos. The targeted LHRH analog AEZS-108 alters expression of genes related to angiogenesis and development of metastasis in uveal melanomaOncotarget 2020; 11(2): 175 doi: 10.18632/oncotarget.27431
Xiaofeng Peng, Kangming Pan, Wenli Zhao, Jianzhu Zhang, Shicheng Yuan, Xiang Wen, Wenquan Zhou, Zhijin Yu. NPTX1 inhibits colon cancer cell proliferation through down-regulating cyclin A2 and CDK2 expressionCell Biology International 2018; 42(5): 589 doi: 10.1002/cbin.10935
Rosemeire M. Kanashiro-Takeuchi, Luca Szalontay, Andrew V. Schally, Lauro M. Takeuchi, Petra Popovics, Miklos Jaszberenyi, Irving Vidaurre, Marta Zarandi, Ren-Zhi Cai, Norman L. Block, Joshua M. Hare, Ferenc G. Rick. New therapeutic approach to heart failure due to myocardial infarction based on targeting growth hormone-releasing hormone receptorOncotarget 2015; 6(12): 9728 doi: 10.18632/oncotarget.3303
Kexin Shen, Ying Zhang, Jianxun Ding, Haishan Zhang. c(RGDfC)-decorated micelle as nanocarrier for targeting therapeutic of colon cancerJournal of Controlled Release 2015; 213: e66 doi: 10.1016/j.jconrel.2015.05.109
Kexin Shen, Di Li, Jingjing Guan, Jianxun Ding, Zhongtang Wang, Jingkai Gu, Tongjun Liu, Xuesi Chen. Targeted sustained delivery of antineoplastic agent with multicomponent polylactide stereocomplex micelleNanomedicine: Nanotechnology, Biology and Medicine 2017; 13(3): 1279 doi: 10.1016/j.nano.2016.12.022
Cédric Seignez, Amandine Martin, Claire-Emmanuelle Rollet, Cindy Racoeur, Alessandra Scagliarini, Jean-François Jeannin, Ali Bettaieb, Catherine Paul. Senescence of tumor cells induced by oxaliplatin increases the efficiency of a lipid A immunotherapy via the recruitment of neutrophilsOncotarget 2014; 5(22): 11442 doi: 10.18632/oncotarget.2556
Ji Sung Kim, Yong Guk Kim, Eun Jae Park, Boyeong Kim, Hong Kyung Lee, Jin Tae Hong, Youngsoo Kim, Sang-Bae Han. Cell-based Immunotherapy for Colorectal Cancer with Cytokine-induced Killer CellsImmune Network 2016; 16(2): 99 doi: 10.4110/in.2016.16.2.99
Kira S Sheinerman, Samuil Umansky. Universal screening test based on analysis of circulating organ-enriched microRNAs: a novel approach to diagnostic screeningExpert Review of Molecular Diagnostics 2015; 15(3): 329 doi: 10.1586/14737159.2014.973858
Jingde Chen, Li Li, Zhuqing Zhou, Shijun Yu, Yandong Li, Yong Gao. FAPP2 promotes tumor cell growth in human colon cancer through activation of Wnt signalingExperimental Cell Research 2019; 374(1): 12 doi: 10.1016/j.yexcr.2018.11.002
Wojciech Jelski, Barbara Mroczko. <p>Biochemical Markers of Colorectal Cancer – Present and Future</p>Cancer Management and Research 2020; : 4789 doi: 10.2147/CMAR.S253369
Petra Popovics, Andrew V. Schally, Luca Szalontay, Norman L. Block, Ferenc G. Rick. Targeted cytotoxic analog of luteinizing hormone-releasing hormone (LHRH), AEZS-108 (AN-152), inhibits the growth of DU-145 human castration-resistant prostate cancerin vivoandin vitrothrough elevating p21 and ROS levelsOncotarget 2014; 5(12): 4567 doi: 10.18632/oncotarget.2146
Carmen Ili, Kurt Buchegger, Hannah Demond, Juan Castillo-Fernandez, Gavin Kelsey, Louise Zanella, Michel Abanto, Ismael Riquelme, Jaime López, Tamara Viscarra, Patricia García, Enrique Bellolio, David Saavedra, Priscilla Brebi. Landscape of Genome-Wide DNA Methylation of Colorectal Cancer MetastasisCancers 2020; 12(9): 2710 doi: 10.3390/cancers12092710
Elif Kadife, Thomas Michael Benjamin Ware, Rodney Brian Luwor, Steven Tuck Foo Chan, Kulmira Nurgali, Paul Vincent Senior. Effects of EphB4 receptor expression on colorectal cancer cells, tumor growth, vascularization and compositionActa Oncologica 2018; 57(8): 1043 doi: 10.1080/0284186X.2018.1429650
Tijen Temiz Kaya, Ahmet Altun, Nergiz Hacer Turgut, Hilmi Ataseven, Gokhan Koyluoglu. Effects of a Multikinase Inhibitor Motesanib (AMG 706) Alone and Combined with the Selective DuP-697 COX-2 Inhibitor on Colorectal Cancer CellsAsian Pacific Journal of Cancer Prevention 2016; 17(3): 1103 doi: 10.7314/APJCP.2016.17.3.1103
Ying Liu, Su An, Richard Ward, Yang Yang, Xiao-Xi Guo, Wei Li, Tian-Rui Xu. G protein-coupled receptors as promising cancer targetsCancer Letters 2016; 376(2): 226 doi: 10.1016/j.canlet.2016.03.031
Dominick Latremouille-Viau, Jane Chang, Annie Guerin, Sherry Shi, Ed Wang, Justin Yu, Christopher Ngai. The economic burden of common adverse events associated with metastatic colorectal cancer treatment in the United StatesJournal of Medical Economics 2017; 20(1): 54 doi: 10.1080/13696998.2016.1225577
Roberto Perez, Andrew V. Schally, Petra Popovics, Renzhi Cai, Wei Sha, Ricardo Rincon, Ferenc G. Rick. Antagonistic analogs of growth hormone-releasing hormone increase the efficacy of treatment of triple negative breast cancer in nude mice with doxorubicin; A preclinical studyOncoscience 2014; 1(10): 665 doi: 10.18632/oncoscience.92
Paola Moreno, Irene Ramos-Álvarez, Terry W. Moody, Robert T. Jensen. Bombesin related peptides/receptors and their promising therapeutic roles in cancer imaging, targeting and treatmentExpert Opinion on Therapeutic Targets 2016; 20(9): 1055 doi: 10.1517/14728222.2016.1164694
Janette Beech, Theodora Germetaki, Mary Judge, Nina Paton, Joanne Collins, Abigail Garbutt, Michael Braun, Jill Fenwick, Mark P Saunders. Management and grading of EGFR inhibitor-induced cutaneous toxicityFuture Oncology 2018; 14(24): 2531 doi: 10.2217/fon-2018-0187
Martin Pesta, Vlastimil Kulda, Andrea Narsanska, Jakub Fichtl, Ondrej Topolcan. May CTC technologies promote better cancer management?EPMA Journal 2015; 6(1) doi: 10.1186/s13167-014-0023-x
Vânia Diogo, Joana Teixeira, Patrícia M.A. Silva, Hassan Bousbaa. Spindle Assembly Checkpoint as a Potential Target in Colorectal Cancer: Current Status and Future PerspectivesClinical Colorectal Cancer 2017; 16(1): 1 doi: 10.1016/j.clcc.2016.06.006